Mental health and alcohol/other drug (AOD) disorders are both at their peak and the leading cause of disability and death worldwide in young people. Comorbidity between AOD and mental health disorders is common, and current treatment approaches often fail to adequately address the risk and protective factors underlying these disorders. Transdiagnostic cognitive behavioural therapy (CBT) cuts across diagnostic boundaries to target the common psychological factors that underlie multiple disorders.
This randomised controlled trial will determine if a new risk and protective factor-targeted transdiagnostic CBT telehealth program (FullFix) for comorbid AOD and mental health problems in young people has better outcomes and is more cost-effective than standard AOD care (case management and AOD counselling).
Co-Investigators: Zoe Walter, Catherine Quinn, Dominique de Andrade, Genevieve Dingle, Maree Toombs, Amanda Baker & Alison Beck